Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 183
Gene Symbol: AGT
AGT
0.010 Biomarker disease BEFREE Angiotensin II modulates amphetamine-induced glial and brain vascular responses, and attention deficit via angiotensin type 1 receptor: Evidence from brain regional sensitivity to amphetamine. 31646669 2020
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.010 Biomarker disease BEFREE Baseline CSF biomarkers (amyloid beta (Aβ) 1-42, Aβ42/40, Tau, and pTau181), interpreted according to the ES, were used to estimate time to progression from the MCI stage of AD to ADD, conditional on age, gender, APOE ε4 genotype, and Mini Mental State Examination score in 144 MCI subjects, using the Extended Cox Model; the subjects were followed-up until they developed dementia or until they had been cognitively stable for at least 2 years. 30611311 2019
Entrez Id: 91752
Gene Symbol: ZNF804A
ZNF804A
0.010 GeneticVariation disease BEFREE ZNF804A rs1344706 C (non-risk) alleles were significantly associated with higher SPQ-B Cognitive-Perceptual subscores in women and with attention deficits in both sexes. 31076262 2019
Entrez Id: 3704
Gene Symbol: ITPA
ITPA
0.010 Biomarker disease BEFREE These results add significantly to our understanding of the NTPase domain of FeoB and its role in Feo function. 30760591 2019
Entrez Id: 84284
Gene Symbol: NTPCR
NTPCR
0.010 Biomarker disease BEFREE These results add significantly to our understanding of the NTPase domain of FeoB and its role in Feo function. 30760591 2019
Entrez Id: 6356
Gene Symbol: CCL11
CCL11
0.010 Biomarker disease BEFREE Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients. 30056534 2019
Entrez Id: 7059
Gene Symbol: THBS3
THBS3
0.010 Biomarker disease BEFREE THBS3 (thrombospondin 3) mRNA and AABA gave a very good biomarker signature (AUC 0,911) for executive-attention deficits. 31235756 2019
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.010 AlteredExpression disease BEFREE Decreased serum orexin A levels in drug-naive children with attention deficit and hyperactivity disorder. 30617449 2019
Entrez Id: 406934
Gene Symbol: MIR142
MIR142
0.010 AlteredExpression disease BEFREE Chronotypical characteristics and related miR-142-3p levels of children with attention deficit and hyperactivity disorder. 30658207 2019
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2
0.010 Biomarker disease BEFREE Baseline CSF biomarkers (amyloid beta (Aβ) 1-42, Aβ42/40, Tau, and pTau181), interpreted according to the ES, were used to estimate time to progression from the MCI stage of AD to ADD, conditional on age, gender, APOE ε4 genotype, and Mini Mental State Examination score in 144 MCI subjects, using the Extended Cox Model; the subjects were followed-up until they developed dementia or until they had been cognitively stable for at least 2 years. 30611311 2019
Entrez Id: 494327
Gene Symbol: MIR378A
MIR378A
0.010 AlteredExpression disease BEFREE To compare children with Attention Deficit and Hyperactivity Disorder (ADHD) and a healthy control group in terms of chronotype characteristics and miRNA-142-3p/miRNA-378 levels. 30658207 2019
Entrez Id: 10479
Gene Symbol: SLC9A6
SLC9A6
0.010 Biomarker disease BEFREE Loss-of-function mutations in human endosomal Na<sup>+</sup>(K<sup>+</sup>)/H<sup>+</sup> exchangers (NHEs) NHE6 and NHE9 are implicated in neurological disorders including Christianson syndrome, autism, and attention deficit and hyperactivity disorder. 29212874 2018
Entrez Id: 5788
Gene Symbol: PTPRC
PTPRC
0.010 GeneticVariation disease BEFREE Neurological function was preserved in the LCA+ group with an exception of attention deficit, which was frequent in the LCA+ group. 29454227 2018
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.010 Biomarker disease BEFREE Twin studies add significant information about the mechanisms of C9orf72 expansion pleiotropism, probably driven by genetic, epigenetic, and environmental factors. 29866399 2018
Entrez Id: 175
Gene Symbol: AGA
AGA
0.010 Biomarker disease BEFREE ADHD: attention deficit hyperactive disorder; AGA: average for gestational age; BMI: body mass index; CP: cerebral palsy; DHT: dihydrotestosterone; FSH: follicle stimulating hormone; LBW: low birth weight; LH: luteinizing hormone; SAD: sagittal abdominal diameter; SGA: small for gestational age; SHBG: sex hormone binding globulin; TSH: thyroid stimulating hormone; T3: triiodothyronine; T4: thyroxin; VLBW: very low birth weight. 29583035 2018
Entrez Id: 117145
Gene Symbol: THEM4
THEM4
0.010 Biomarker disease BEFREE 3,4-dichloromethylphenidate (3,4-CTMP) and ethylphenidate are new psychoactive substances and analogs of the attention deficit medication methylphenidate. 29892233 2018
Entrez Id: 285195
Gene Symbol: SLC9A9
SLC9A9
0.010 Biomarker disease BEFREE Loss-of-function mutations in human endosomal Na<sup>+</sup>(K<sup>+</sup>)/H<sup>+</sup> exchangers (NHEs) NHE6 and NHE9 are implicated in neurological disorders including Christianson syndrome, autism, and attention deficit and hyperactivity disorder. 29212874 2018
Entrez Id: 1211
Gene Symbol: CLTA
CLTA
0.010 GeneticVariation disease BEFREE Neurological function was preserved in the LCA+ group with an exception of attention deficit, which was frequent in the LCA+ group. 29454227 2018
Entrez Id: 7173
Gene Symbol: TPO
TPO
0.010 GeneticVariation disease BEFREE Our comparative study of cognitive impairment in MSA-P and MSA-C showed that both groups had impaired executive and visuospatial functions, while the attention deficit was predominant only in MSA-C. 29223069 2018
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.010 AlteredExpression disease BEFREE Association between increased serum interleukin-6 levels and sustained attention deficits in patients with major depressive disorder. 29415791 2018
Entrez Id: 30833
Gene Symbol: NT5C
NT5C
0.010 Biomarker disease BEFREE Growing concern suggests that some chemicals exert (developmental) neurotoxicity (DNT and NT) and are linked to the increase in incidence of autism, attention deficit and hyperactivity disorders. 29428530 2018
Entrez Id: 3000
Gene Symbol: GUCY2D
GUCY2D
0.010 GeneticVariation disease BEFREE Neurological function was preserved in the LCA+ group with an exception of attention deficit, which was frequent in the LCA+ group. 29454227 2018
Entrez Id: 8553
Gene Symbol: BHLHE40
BHLHE40
0.010 Biomarker disease BEFREE These findings show that Nr3c1-Bhlhb2 axis dysregulation was involved in the development of attention deficit and hyperactivity. 26820676 2017
Entrez Id: 3251
Gene Symbol: HPRT1
HPRT1
0.010 AlteredExpression disease BEFREE Complete deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT) activity causes Lesch Nyhan disease (LND), characterized by hyperuricemia, severe action dystonia, choreoathetosis, ballismus, cognitive and attention deficit and self-injurious behavior. 28782500 2017
Entrez Id: 590
Gene Symbol: BCHE
BCHE
0.010 GeneticVariation disease BEFREE Exposures to cholinesterase inhibitor pesticides (e.g. organophosphates) have been associated with children's neurobehavioral alterations, including attention deficit and impulsivity. 28188819 2017